Related Experiment Video

Updated: Jun 17, 2026

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model
13:41

Magnetic Resonance-Guided High Intensity Focused Ultrasound Generated Hyperthermia: A Feasible Treatment Method in a Murine Rhabdomyosarcoma Model

Published on: January 13, 2023

RhoGDI2 as a therapeutic target in cancer

Hee Jun Cho1, Kyoung Eun Baek, Jiyun Yoo

  • 1Gyeongsang National University, College of Natural Sciences, Research Institute of Life Science, Department of Microbiology, Jinju 660-701, Korea.

Expert Opinion on Therapeutic Targets
|December 17, 2009
PubMed
Abstract

Insights

Rho GDP dissociation inhibitor 2 (RhoGDI2) regulates cancer cell invasion and metastasis by controlling Rac1 activity. Targeting RhoGDI2 offers a potential therapeutic strategy for aggressive cancers.

Area of Science:

  • Oncology
  • Molecular Biology
  • Cancer Metastasis Research

Background:

  • Rho GDP dissociation inhibitor 2 (RhoGDI2) regulates Rho GTPases involved in cancer progression.
  • Aberrant RhoGDI2 expression in human cancers correlates with aggressive phenotypes like invasion and metastasis.
  • RhoGDI2 is a potential therapeutic target due to its role in malignant progression.

Purpose of the Study:

  • To review the role of RhoGDI2 in cancer metastasis.
  • To discuss RhoGDI2 as a therapeutic target for cancer treatment.

Main Methods:

  • Literature review summarizing RhoGDI2's function in human cancers.
  • Analysis of RhoGDI2's role in metastasis-related processes.
  • Discussion of therapeutic strategies targeting RhoGDI2.

Main Results:

  • RhoGDI2 influences cancer cell invasiveness and metastatic potential.
  • Regulation of Rac1 activity by RhoGDI2 is a key mechanism in metastasis.
  • RhoGDI2's role in modulating cancer cell motility and invasion.

Conclusions:

  • RhoGDI2 may serve as a biomarker for tumor progression.
  • Interruption of RhoGDI2-mediated metastasis presents a promising therapeutic avenue.
  • Targeting RhoGDI2 offers a potential strategy to combat cancer invasion and metastasis.

Related Concept Videos

Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
Cancer Therapies02:49

Cancer Therapies

Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
Hedgehog Signaling Pathway02:33

Hedgehog Signaling Pathway

The Hedgehog gene (Hh) was first discovered due to its control of the growth of disorganized, hair-like bristles phenotype in Drosophila, much like hedgehog spines. Hh plays a crucial role in the development of organs and the maintenance of homeostasis in both invertebrates and vertebrates. However, while Drosophila has only one Hh protein, mammals have multiple functional Hedgehog proteins - Sonic (Shh), Desert (Dhh), and Indian Hedgehog (Ihh). All of these homologous proteins have adapted to...
Small GTPases - Ras and Rho01:24

Small GTPases - Ras and Rho

Ras and Rho are small monomeric GTPases that act downstream of receptor tyrosine kinase (RTK) and regulate various cellular processes. These GTPases switch between active and inactive states by binding to guanine nucleotides.
Three regulatory proteins control their activity: